Page last updated: 2024-08-21

oxazoles and Bacterial Infections, Gram-Positive

oxazoles has been researched along with Bacterial Infections, Gram-Positive in 35 studies

Research

Studies (35)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	9 (25.71)	18.2507
2000's	5 (14.29)	29.6817
2010's	19 (54.29)	24.3611
2020's	2 (5.71)	2.80

Authors

Authors	Studies
Amann, LF; Huang, J; Iqbal, K; Rohde, H; Tikiso, T; Wicha, SG; Zeitlinger, M	1
Ang, JY; Arrieta, AC; Bradley, JS; Chou, MZ; De Anda, CS; Espinosa, C; Fofanov, O; Kim, JY; Li, D; Sabato, P; Sears, PS; Tøndel, C	1
Asai, N; Hagihara, M; Kato, H; Koizumi, Y; Matsuura, K; Mikamo, H; Nishiyama, N; Sakanashi, D; Suematsu, H; Yamagishi, Y	1
Auzou, M; Cattoir, V; Compain, F; Michon, J; Piau-Couapel, C; Ract, P	1
Moellering, RC	1
Martin, CA; Marx, K; Rybak, JM	1
Bartizal, KF; Bien, PA; Deane, J; Locke, JB; Sahm, DF; Shaw, KJ; Zuill, DE	1
Adam, H; Gilmour, M; Gin, AS; Golden, A; Gorityala, B; Hoban, DJ; Karlowsky, JA; Lagacé-Wiens, PR; Love, R; Lynch, JP; Rubinstein, E; Schweizer, F; Walkty, A; Zelenitsky, S; Zhanel, GG	1
Burdette, SD; Trotman, R	1
Chahine, EB; Knutsen, SD; Sucher, AJ	1
Choi, S; Hong, SK; Im, W; Lee, K; Lee, Y; Yong, D	1
Mensa, J; Morata, L; Soriano, A	1
Chen, KH; Hsueh, PR; Huang, YT; Liao, CH; Sheng, WH	1
Douros, A; Grabowski, K; Stahlmann, R	1
Barber, KE; Raut, A; Rybak, MJ; Smith, JR	1
Burnham, CA; Crotty, MP; Krekel, T; Ritchie, DJ	1
Farrell, DJ; Flamm, RK; Jones, RN; Mendes, RE; Pfaller, MA	1
Aepfelbacher, M; Belmar Campos, C; Both, A; Büttner, H; Christner, M; Christopeit, M; Klupp, EM; König, C; Rohde, H	1
Cao, B; Chen, H; Chu, Y; Du, Y; Feng, X; Fu, Q; Gui, Q; Guo, Y; Hu, B; Hu, Y; Hu, Z; Ji, P; Jia, W; Jin, Y; Lei, JE; Li, S; Liao, K; Liu, Z; Ni, Y; Wang, H; Wang, Z; Xu, X; Yang, Q; Yu, Y; Zeng, J; Zhang, R; Zhang, Z; Zhao, C; Zhuo, C	1
Bensaci, M; Sahm, D	1
Bien, P; Bulitta, JB; Corey, GR; DeAnda, C; Mehra, P; Prokocimer, P; Surber, J	1
Holzgrabe, U	1
Batts, DH; Daley-Yates, PT; Pawsey, SD; Schaadt, RD; Stalker, DJ; Zurenko, GE	1
Andrews, JM; Ashby, JP; Boswell, FJ; Wise, R	1
Kruzynski, J; Noskin, GA; Peterson, LR; Siddiqui, F; Stosor, V	1
Patel, R; Piper, KE; Rouse, MS; Steckelberg, JM	1
Eliopoulos, GM; Moellering, RC; Schülin, T; Thauvin-Eliopoulos, C	1
Abdel-Rahman, SM; Kearns, GL	1
Chien, JW; Kucia, ML; Salata, RA	1
Chandrasekar, PH; Clark, NM; Kauffman, CA; McNeil, SA	1
MacConnachie, AM	1
Lundstrom, TS; Sobel, JD	1
Flanagan, PG; Penrose-Stevens, A; Pitman, I; Simpson, BA; Tan, TY	1

Reviews

12 review(s) available for oxazoles and Bacterial Infections, Gram-Positive

Article	Year
Tedizolid: a novel oxazolidinone for Gram-positive infections. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2014, Volume: 58 Suppl 1 Topics: Anti-Bacterial Agents; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Organophosphates; Oxazoles; Oxazolidinones	2014
Early experience with tedizolid: clinical efficacy, pharmacodynamics, and resistance. Pharmacotherapy, 2014, Volume: 34, Issue:11 Topics: Animals; Anti-Bacterial Agents; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drugs, Investigational; Gram-Positive Bacterial Infections; Humans; Methicillin-Resistant Staphylococcus aureus; Organophosphates; Oxazoles; Prodrugs; Staphylococcal Infections; Vancomycin-Resistant Enterococci	2014
Tedizolid: a novel oxazolidinone with potent activity against multidrug-resistant gram-positive pathogens. Drugs, 2015, Volume: 75, Issue:3 Topics: Animals; Anti-Bacterial Agents; Clinical Trials as Topic; Drug Resistance, Multiple, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Molecular Structure; Organophosphates; Oxazoles; Skin Diseases, Bacterial	2015
Tedizolid: The First Once-Daily Oxazolidinone Class Antibiotic. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2015, Oct-15, Volume: 61, Issue:8 Topics: Anti-Bacterial Agents; Clinical Trials, Phase III as Topic; Drug Interactions; Drug Resistance, Bacterial; Gram-Positive Bacterial Infections; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Organophosphates; Oxazoles; Skin Diseases, Bacterial; Staphylococcal Skin Infections	2015
Tedizolid: A New Oxazolidinone Antibiotic for Skin and Soft Tissue Infections. The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists, 2015, Volume: 30, Issue:7 Topics: Adult; Anti-Bacterial Agents; Drug Interactions; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Organophosphates; Oxazoles; Skin Diseases, Bacterial; Soft Tissue Infections	2015
New antibiotics against gram-positives: present and future indications. Current opinion in pharmacology, 2015, Volume: 24 Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Cephalosporins; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Oxazoles	2015
Drug-drug interactions and safety of linezolid, tedizolid, and other oxazolidinones. Expert opinion on drug metabolism & toxicology, 2015, Volume: 11, Issue:12 Topics: Animals; Anti-Bacterial Agents; Drug Interactions; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Organophosphates; Oxazoles; Oxazolidinones; Structure-Activity Relationship	2015
New Gram-Positive Agents: the Next Generation of Oxazolidinones and Lipoglycopeptides. Journal of clinical microbiology, 2016, Volume: 54, Issue:9 Topics: Anti-Infective Agents; Drug Approval; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Organophosphates; Oxazoles; Teicoplanin; United States; Vancomycin-Resistant Enterococci	2016
[And the path grows wider...ketolides and oxazolidinones in the pipeline]. Pharmazie in unserer Zeit, 2004, Volume: 33, Issue:1 Topics: Anti-Bacterial Agents; Gram-Positive Bacterial Infections; Humans; Oxazoles	2004
An update on the oxazolidinone antibiotics. The Pediatric infectious disease journal, 1999, Volume: 18, Issue:12 Topics: Acetamides; Anti-Infective Agents; Drug Resistance, Microbial; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones	1999
New antibiotics for gram positive infections: linezolid and combination quinapristin/dalfopristin. Intensive & critical care nursing, 1999, Volume: 15, Issue:4 Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Drug Prescriptions; Drug Resistance, Microbial; Drug Therapy, Combination; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazoles; Oxazolidinones; Safety; Virginiamycin	1999
Antibiotics for gram-positive bacterial infections. Vancomycin, teicoplanin, quinupristin/dalfopristin, and linezolid. Infectious disease clinics of North America, 2000, Volume: 14, Issue:2 Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Microbial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazoles; Oxazolidinones; Teicoplanin; Vancomycin; Virginiamycin	2000

Trials

4 trial(s) available for oxazoles and Bacterial Infections, Gram-Positive

Article	Year
Pharmacokinetics and Safety of Single-dose Tedizolid Phosphate in Children 2 to <12 Years of Age. The Pediatric infectious disease journal, 2021, 04-01, Volume: 40, Issue:4 Topics: Administration, Intravenous; Administration, Oral; Anti-Bacterial Agents; Child; Child, Preschool; Female; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Hospitalization; Humans; Male; Organophosphates; Oxazoles	2021
Phase 2, randomized, double-blind, dose-ranging study evaluating the safety, tolerability, population pharmacokinetics, and efficacy of oral torezolid phosphate in patients with complicated skin and skin structure infections. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:2 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Double-Blind Method; Female; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Organophosphates; Oxazoles; Oxazolidinones; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Skin Infections; Staphylococcus aureus; Treatment Outcome; Young Adult	2011
Serum inhibitory titers and serum bactericidal titers for human subjects receiving multiple doses of the antibacterial oxazolidinones eperezolid and linezolid. Diagnostic microbiology and infectious disease, 1997, Volume: 28, Issue:4 Topics: Acetamides; Administration, Oral; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Enterococcus faecalis; Gram-Positive Bacterial Infections; Humans; Injections, Intravenous; Linezolid; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Pneumococcal Infections; Staphylococcal Infections; Staphylococcus aureus; Streptococcus pneumoniae	1997
Use of linezolid, an oxazolidinone, in the treatment of multidrug-resistant gram-positive bacterial infections. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2000, Volume: 30, Issue:1 Topics: Acetamides; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Drug Resistance, Microbial; Drug Resistance, Multiple; Enterococcus; Epidural Abscess; Female; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Oxazoles; Oxazolidinones; Parotitis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin Resistance	2000

Other Studies

19 other study(ies) available for oxazoles and Bacterial Infections, Gram-Positive

Article	Year
A pharmacokinetic-pharmacodynamic (PKPD) model-based analysis of tedizolid against enterococci using the hollow-fibre infection model. The Journal of antimicrobial chemotherapy, 2022, 08-25, Volume: 77, Issue:9 Topics: Animals; Anti-Bacterial Agents; Enterococcus; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Organophosphates; Oxazoles; Oxazolidinones; Tetrazoles	2022
Efficacy of tedizolid against methicillin-resistant Staphylococcus aureus and Peptostreptococcus anaerobius in thigh mixed-infection mouse model. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2017, Volume: 23, Issue:6 Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Female; Gram-Positive Bacterial Infections; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Organophosphates; Oxazoles; Peptostreptococcus; Staphylococcal Infections; Thigh	2017
In vitro activity of tedizolid and comparator agents against Gram-positive pathogens responsible for bone and joint infections. Journal of medical microbiology, 2017, Volume: 66, Issue:10 Topics: Anti-Bacterial Agents; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Joint Diseases; Microbial Sensitivity Tests; Organophosphates; Osteomyelitis; Oxazoles	2017
Results of the surveillance of Tedizolid activity and resistance program: in vitro susceptibility of gram-positive pathogens collected in 2011 and 2012 from the United States and Europe. Diagnostic microbiology and infectious disease, 2015, Volume: 81, Issue:2 Topics: Acetamides; Anti-Bacterial Agents; Epidemiological Monitoring; Europe; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Mutation; Organophosphates; Oxazoles; Oxazolidinones; Ribosomal Proteins; RNA, Ribosomal, 23S; United States	2015
In vitro activity of tedizolid against gram-positive bacteria in patients with skin and skin structure infections and hospital-acquired pneumonia: a Korean multicenter study. Annals of laboratory medicine, 2015, Volume: 35, Issue:5 Topics: Anti-Bacterial Agents; Asian People; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Hospitals; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Organophosphates; Oxazoles; Pneumonia; Republic of Korea; Skin; Skin Diseases	2015
In Vitro Activities of Tedizolid and Linezolid against Gram-Positive Cocci Associated with Acute Bacterial Skin and Skin Structure Infections and Pneumonia. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:10 Topics: Acute Disease; Anti-Bacterial Agents; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Organophosphates; Oxazoles; Pneumonia, Bacterial; Staphylococcal Skin Infections; Streptococcal Infections; Streptococcus agalactiae; Streptococcus anginosus; Streptococcus pyogenes; Taiwan; Vancomycin-Resistant Enterococci	2015
Evaluation of tedizolid against Staphylococcus aureus and enterococci with reduced susceptibility to vancomycin, daptomycin or linezolid. The Journal of antimicrobial chemotherapy, 2016, Volume: 71, Issue:1 Topics: Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Organophosphates; Oxazoles; Staphylococcus aureus; Vancomycin	2016
Activities of Tedizolid and Linezolid Determined by the Reference Broth Microdilution Method against 3,032 Gram-Positive Bacterial Isolates Collected in Asia-Pacific, Eastern Europe, and Latin American Countries in 2014. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:9 Topics: Anti-Bacterial Agents; Asia; Enterococcus faecalis; Europe, Eastern; Gram-Positive Bacterial Infections; Humans; Latin America; Linezolid; Microbial Sensitivity Tests; Organophosphates; Oxazoles; Staphylococcus aureus; Streptococcus agalactiae; Streptococcus pyogenes	2016
Tedizolid susceptibility in linezolid- and vancomycin-resistant Enterococcus faecium isolates. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2016, Volume: 35, Issue:12 Topics: Anti-Bacterial Agents; DNA, Bacterial; DNA, Ribosomal; Drug Resistance, Bacterial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Mutation; Organophosphates; Oxazoles; RNA, Ribosomal, 23S; Vancomycin-Resistant Enterococci	2016
In vitro activities of tedizolid compared with other antibiotics against Gram-positive pathogens associated with hospital-acquired pneumonia, skin and soft tissue infection and bloodstream infection collected from 26 hospitals in China. Journal of medical microbiology, 2016, Volume: 65, Issue:10 Topics: Anti-Bacterial Agents; China; Cross Infection; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Hospitals; Humans; Microbial Sensitivity Tests; Organophosphates; Oxazoles; Pneumonia, Bacterial; Sepsis; Skin Diseases, Bacterial; Soft Tissue Infections	2016
Surveillance of tedizolid activity and resistance: In vitro susceptibility of Gram-positive pathogens collected over 5 years from the United States and Europe. Diagnostic microbiology and infectious disease, 2017, Volume: 87, Issue:2 Topics: Anti-Bacterial Agents; Epidemiological Monitoring; Europe; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Organophosphates; Oxazoles; United States	2017
The in-vitro activity of linezolid (U-100766) and tentative breakpoints. The Journal of antimicrobial chemotherapy, 1998, Volume: 42, Issue:6 Topics: Acetamides; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacteroides fragilis; Bacteroides Infections; Colony Count, Microbial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Time Factors	1998
Successful treatment of persistent vancomycin-resistant Enterococcus faecium bacteremia with linezolid and gentamicin. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1999, Volume: 28, Issue:3 Topics: Acetamides; Adult; Anti-Bacterial Agents; Bacteremia; Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus faecium; Female; Gentamicins; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Vancomycin	1999
In vitro activity of linezolid against vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus and penicillin-resistant Streptococcus pneumoniae. Diagnostic microbiology and infectious disease, 1999, Volume: 34, Issue:2 Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Penicillin Resistance; Pneumococcal Infections; Staphylococcal Infections; Staphylococcus aureus; Streptococcus pneumoniae; Vancomycin	1999
Battling drug resistance. Journal of the American Dental Association (1939), 1999, Volume: 130, Issue:11 Topics: Anti-Bacterial Agents; Clinical Trials as Topic; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Oxazoles; Oxazolidinones; Streptococcal Infections; Streptococcus pyogenes; Vancomycin Resistance; Virginiamycin	1999
Activities of the oxazolidinones linezolid and eperezolid in experimental intra-abdominal abscess due to Enterococcus faecalis or vancomycin-resistant Enterococcus faecium. Antimicrobial agents and chemotherapy, 1999, Volume: 43, Issue:12 Topics: Abdominal Abscess; Acetamides; Animals; Anti-Bacterial Agents; Drug Resistance, Microbial; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Linezolid; Male; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Rats; Rats, Sprague-Dawley; Treatment Outcome; Vancomycin	1999
[Antibiosis. Therapeutic strategies in intensive care]. Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen, 1999, Volume: 70, Issue:11 Suppl Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Critical Care; Drug Therapy; Gram-Positive Bacterial Infections; Humans; Linezolid; Needs Assessment; Oxazoles; Oxazolidinones	1999
Successful treatment of vancomycin-resistant Enterococcus faecium bacteremia with linezolid after failure of treatment with synercid (quinupristin/dalfopristin). Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2000, Volume: 30, Issue:2 Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Bone Marrow Transplantation; Drug Administration Schedule; Drug Therapy, Combination; Enterococcus faecium; Follow-Up Studies; Gram-Positive Bacterial Infections; Humans; Leukemia, Myeloid, Acute; Linezolid; Male; Middle Aged; Oxazoles; Oxazolidinones; Postoperative Complications; Treatment Failure; Treatment Outcome; Vancomycin Resistance; Virginiamycin	2000
Treatment of a vancomycin-resistant Enterococcus faecium ventricular drain infection with quinupristin/dalfopristin and review of the literature. The Journal of infection, 2000, Volume: 41, Issue:1 Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Enterococcus faecium; Fatal Outcome; Female; Gram-Positive Bacterial Infections; Humans; Hydrocephalus; Injections, Intravenous; Injections, Intraventricular; Injections, Spinal; Linezolid; Middle Aged; Oxazoles; Oxazolidinones; Subarachnoid Hemorrhage; Tomography, X-Ray Computed; Vancomycin; Ventriculoperitoneal Shunt; Virginiamycin	2000